tradingkey.logo
tradingkey.logo
Search

Editas Medicine Inc

EDIT
Add to Watchlist
2.570USD
-0.100-3.75%
Close 11-02 16:00(ET)
394.70MMarket Cap
LossP/E TTM

Today

-3.75%

5 Days

+7.08%

1 Month

-1.91%

6 Months

-11.38%

Year to Date

+25.37%

1 Year

-16.56%

Key Figures

2.710Open
2.778High
209.50KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.14%Turnover Ratio
2.670Prev. Close
2.550Low
550.59KTurnover
LossP/E Static
3.74P/B
0.00%Div Yield TTM
-52.76%ROA
3.94052wk High
0.08Volume Ratio
-237.09MNet Profit
153.58MShares
-1.1427EPS TTM
2.16Beta
-326.07%ROE
1.66052wk Low
13.86%Amplitude
100.00%Gross Margin
394.70MMarket Cap
-0.41Reward/Risk
5.21%Risk Rate
Recent
Earnings
More news coming soon, stay tuned...

Editas Medicine Inc's Score

0.31vs previous score
Forecast7.69
Financial Health9.04
Technical5.04
Valuation Dimensions6.38
Institutional Confidence5.00
Risk Assessment3.50

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
6.250Target Price
+111.86%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy44322222
Buy55456666
Hold22333344
Sell22222222
Strong Sell00000000

Editas Medicine Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.15/-0.27
Revenue / Forecast
11.89M/2.80M

Editas Medicine Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolEDIT
Number of employees246
CountryUnited States of America

Ownership

ShareholdersProportion
BlackRock Institutional Trust Company, N.A.7.77%
Vanguard Capital Management, LLC4.29%
Vanguard Portfolio Management, LLC3.22%
Renaissance Technologies LLC3.10%
Shareholder TypesProportion
Investment Advisor25.19%
Investment Advisor/Hedge Fund11.65%
Hedge Fund10.25%
Research Firm4.22%

FAQs

What is the current price of Editas Medicine Inc (EDIT)?

The current price of Editas Medicine Inc (EDIT) is 2.57.

What is the symbol of Editas Medicine Inc?

The ticker symbol of Editas Medicine Inc is EDIT.

What is the 52-week high of Editas Medicine Inc?

The 52-week high of Editas Medicine Inc is 3.94.

What is the 52-week low of Editas Medicine Inc?

The 52-week low of Editas Medicine Inc is 1.66.

What is the market capitalization of Editas Medicine Inc?

The market capitalization of Editas Medicine Inc is 394.70M.

Is Editas Medicine Inc (EDIT) currently rated as Buy, Hold, or Sell?

According to analysts, Editas Medicine Inc (EDIT) has an overall rating of Buy, with a price target of 6.25.

What is the Earnings Per Share (EPS TTM) of Editas Medicine Inc (EDIT)?

The Earnings Per Share (EPS TTM) of Editas Medicine Inc (EDIT) is -1.14.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.